FDA Approves Psoriasis Drug Raptiva. By TSC Staff The Food and Drug Administration approved Monday a new psoriasis drug from biotech firms Genentech (DNA:NYSE) and Xoma Dave's Prosiasis Info - Review of Drug InfoNet when looking for detailed information about psoriasis, Drug InfoNet should probably be avoided in of the National Psoriasis Foundation (about which Drug InfoNet is silent). When This website provides detailed information on drug new psoriasis. Drug for Psoriasis (National Psoriasis Foundation) Genentech Says New Psoriasis Drug Batches Match Earlier Version Genentech Says New Psoriasis Drug Batches Match Earlier Version Raptiva, from Genentech and Xoma, will compete with drugs from Amgen and Biogen. The Food and Drug Administration approved Monday a new psoriasis drug from biotech firms Genentech (DNA:NYSE A critical review of some deceptive psoriasis treatments promoted on the net. an OTC drug. This allows the company to legally make various safety and efficacy claims for treating psoriasis, and they Raptiva, from Genentech and Xoma, will compete with drugs from Amgen and Biogen. The Food and Drug Administration approved Monday a new psoriasis drug from biotech firms Genentech (DNA:NYSE
